• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在接受质子泵抑制剂成功治疗的基层医疗患者中,与胃食管反流病复发相关的危险因素。

Risk factors associated with gastroesophageal reflux disease relapse in primary care patients successfully treated with a proton pump inhibitor.

作者信息

López-Colombo A, Pacio-Quiterio M S, Jesús-Mejenes L Y, Rodríguez-Aguilar J E G, López-Guevara M, Montiel-Jarquín A J, López-Alvarenga J C, Morales-Hernández E R, Ortiz-Juárez V R, Ávila-Jiménez L

机构信息

Dirección de Educación e Investigación, UMAE Hospital de Especialidades CMN Manuel Ávila Camacho, Instituto Mexicano del Seguro Social, Puebla, México.

Unidad de Medicina Familiar Número 1, Instituto Mexicano del Seguro Social, Puebla, México.

出版信息

Rev Gastroenterol Mex. 2017 Apr-Jun;82(2):106-114. doi: 10.1016/j.rgmx.2016.09.001. Epub 2017 Mar 7.

DOI:10.1016/j.rgmx.2016.09.001
PMID:28283313
Abstract

BACKGROUND

There are no studies on the factors associated with gastroesophageal reflux disease (GERD) relapse in primary care patients.

AIM

To identify the risk factors associated with GERD relapse in primary care patients that responded adequately to short-term treatment with a proton pump inhibitor.

PATIENTS AND METHODS

A cohort study was conducted that included GERD incident cases. The patients received treatment with omeprazole for 4 weeks. The ReQuest questionnaire and a risk factor questionnaire were applied. The therapeutic success rate and relapse rate were determined at 4 and 12 weeks after treatment suspension. A logistic regression analysis of the possible risk factors for GERD relapse was carried out.

RESULTS

Of the 83 patient total, 74 (89.16%) responded to treatment. Symptoms recurred in 36 patients (48.64%) at 4 weeks and in 13 patients (17.57%) at 12 weeks, with an overall relapse rate of 66.21%. The OR multivariate analysis (95% CI) showed the increases in the possibility of GERD relapse for the following factors at 12 weeks after treatment suspension: basic educational level or lower, 24.95 (1.92-323.79); overweight, 1.76 (0.22-13.64); obesity, 0.25 (0.01-3.46); smoking, 0.51 (0.06-3.88); and the consumption of 4-12 cups of coffee per month, 1.00 (0.12-7.84); citrus fruits, 14.76 (1.90-114.57); NSAIDs, 27.77 (1.12-686.11); chocolate, 0.86 (0.18-4.06); ASA 1.63 (0.12-21.63); carbonated beverages, 4.24 (0.32-55.05); spicy food 7-16 times/month, 1.39 (0.17-11.17); and spicy food ≥ 20 times/month, 4.06 (0.47-34.59).

CONCLUSIONS

The relapse rate after short-term treatment with omeprazole was high. The consumption of citrus fruits and NSAIDs increased the possibility of GERD relapse.

摘要

背景

目前尚无关于基层医疗患者胃食管反流病(GERD)复发相关因素的研究。

目的

确定对质子泵抑制剂短期治疗反应良好的基层医疗患者中GERD复发的危险因素。

患者与方法

进行了一项队列研究,纳入GERD新发病例。患者接受奥美拉唑治疗4周。应用ReQuest问卷和危险因素问卷。在停药后4周和12周确定治疗成功率和复发率。对GERD复发的可能危险因素进行逻辑回归分析。

结果

83例患者中,74例(89.16%)对治疗有反应。4周时36例患者(48.64%)症状复发,12周时13例患者(17.57%)症状复发,总体复发率为66.21%。多因素OR分析(95%CI)显示,停药后12周以下因素会增加GERD复发的可能性:基础教育水平及以下,24.95(1.92 - 323.79);超重,1.76(0.22 - 13.64);肥胖,0.25(0.01 - 3.46);吸烟,0.51(0.06 - 3.88);每月饮用4 - 12杯咖啡,1.00(0.12 - 7.84);柑橘类水果,14.76(1.90 - 114.57);非甾体抗炎药,27.77(1.12 - 686.11);巧克力,0.86(0.18 - 4.06);阿司匹林,1.63(0.12 - 21.63);碳酸饮料,4.24(0.32 - 55.05);每月食用辛辣食物7 - 16次,1.39(0.17 - 11.17);每月食用辛辣食物≥20次,4.06(0.47 - 34.59)。

结论

奥美拉唑短期治疗后的复发率较高。食用柑橘类水果和非甾体抗炎药会增加GERD复发的可能性。

相似文献

1
Risk factors associated with gastroesophageal reflux disease relapse in primary care patients successfully treated with a proton pump inhibitor.在接受质子泵抑制剂成功治疗的基层医疗患者中,与胃食管反流病复发相关的危险因素。
Rev Gastroenterol Mex. 2017 Apr-Jun;82(2):106-114. doi: 10.1016/j.rgmx.2016.09.001. Epub 2017 Mar 7.
2
[What is the utility of proton pump inhibitor testing in non-cardiac chest pain?].[质子泵抑制剂检测在非心源性胸痛中的作用是什么?]
Gastroenterol Hepatol. 2014 Oct;37(8):452-61. doi: 10.1016/j.gastrohep.2014.02.009. Epub 2014 Apr 13.
3
Effect of wu chu yu tang on gastroesophageal reflux disease: Randomized, double-blind, placebo-controlled trial.乌珠俞汤治疗胃食管反流病的疗效:随机、双盲、安慰剂对照试验。
Phytomedicine. 2019 Mar 15;56:118-125. doi: 10.1016/j.phymed.2018.09.185. Epub 2018 Sep 18.
4
Epidemiological study on the incidence of gastroesophageal reflux disease symptoms in patients in acute treatment with NSAIDs.非甾体抗炎药急性治疗患者胃食管反流病症状发生率的流行病学研究。
Expert Rev Gastroenterol Hepatol. 2013 Jan;7(1):27-33. doi: 10.1586/egh.12.61.
5
Randomized controlled trial comparing the efficacy of mosapride plus omeprazole combination therapy to omeprazole monotherapy in gastroesophageal reflux disease.比较莫沙必利联合奥美拉唑与奥美拉唑单药治疗胃食管反流病疗效的随机对照试验
J Dig Dis. 2014 Sep;15(9):469-76. doi: 10.1111/1751-2980.12167.
6
The Prevalence and Clinical Features of Non-responsive Gastroesophageal Reflux Disease to Practical Proton Pump Inhibitor Dose in Korea: A Multicenter Study.韩国对标准质子泵抑制剂剂量无反应的胃食管反流病的患病率及临床特征:一项多中心研究
Korean J Gastroenterol. 2016 Jul 25;68(1):16-22. doi: 10.4166/kjg.2016.68.1.16.
7
Prevalence of gastro-esophageal reflux disease in patients with difficult to control asthma and effect of proton pump inhibitor therapy on asthma symptoms, reflux symptoms, pulmonary function and requirement for asthma medications.难治性哮喘患者胃食管反流病的患病率以及质子泵抑制剂治疗对哮喘症状、反流症状、肺功能和哮喘药物需求的影响。
J Postgrad Med. 2014 Jul-Sep;60(3):282-6. doi: 10.4103/0022-3859.138754.
8
Gastroesophageal reflux disease in primary care: using changes in proton pump inhibitor therapy as an indicator of partial response.基层医疗中的胃食管反流病:以质子泵抑制剂治疗的变化作为部分缓解的指标
Scand J Gastroenterol. 2012 Jul;47(7):751-61. doi: 10.3109/00365521.2012.679682. Epub 2012 Apr 23.
9
Risk factors and prescription patterns of gastroesophageal reflux disease: HEAL study in Pakistan.胃食管反流病的风险因素及处方模式:巴基斯坦的HEAL研究
J Pak Med Assoc. 2014 Jul;64(7):751-7.
10
Low levels of adherence with proton pump inhibitor therapy contribute to therapeutic failure in gastroesophageal reflux disease.质子泵抑制剂治疗的低依从性导致胃食管反流病的治疗失败。
Dis Esophagus. 2012 Feb;25(2):107-13. doi: 10.1111/j.1442-2050.2011.01227.x. Epub 2011 Jul 21.

引用本文的文献

1
Prevalence and risk factors of gastroesophageal reflux disease in Iran: A cross-sectional analysis from the PERSIAN cohort.伊朗胃食管反流病的患病率及危险因素:PERSIAN 队列的横断面分析。
PLoS One. 2024 Jul 11;19(7):e0306223. doi: 10.1371/journal.pone.0306223. eCollection 2024.
2
Differences in Dietary and Lifestyle Triggers between Non-Erosive Reflux Disease and Reflux Esophagitis-A Multicenter Cross-Sectional Survey in China.非糜烂性反流病和反流性食管炎饮食及生活方式触发因素的差异:中国多中心横断面调查。
Nutrients. 2023 Jul 31;15(15):3400. doi: 10.3390/nu15153400.
3
Dietary Intake in Relation to the Risk of Reflux Disease: A Systematic Review.
饮食摄入与反流性疾病风险的关系:一项系统综述。
Prev Nutr Food Sci. 2021 Dec 31;26(4):367-379. doi: 10.3746/pnf.2021.26.4.367.
4
Dietary and Lifestyle Factors Related to Gastroesophageal Reflux Disease: A Systematic Review.与胃食管反流病相关的饮食和生活方式因素:一项系统综述。
Ther Clin Risk Manag. 2021 Apr 15;17:305-323. doi: 10.2147/TCRM.S296680. eCollection 2021.
5
Patients with acid, high-fat and low-protein diet have higher laryngopharyngeal reflux episodes at the impedance-pH monitoring.在阻抗-pH 监测中,胃酸、高脂肪和低蛋白饮食的患者会出现更高的咽喉反流事件。
Eur Arch Otorhinolaryngol. 2020 Feb;277(2):511-520. doi: 10.1007/s00405-019-05711-2. Epub 2019 Nov 2.
6
Development of scores assessing the refluxogenic potential of diet of patients with laryngopharyngeal reflux.开发评估喉咽反流患者饮食反流倾向的评分。
Eur Arch Otorhinolaryngol. 2019 Dec;276(12):3389-3404. doi: 10.1007/s00405-019-05631-1. Epub 2019 Sep 12.
7
Beneficial effect of probiotics supplements in reflux esophagitis treated with esomeprazole: A randomized controlled trial.益生菌补充剂对埃索美拉唑治疗反流性食管炎的有益作用:一项随机对照试验。
World J Gastroenterol. 2019 May 7;25(17):2110-2121. doi: 10.3748/wjg.v25.i17.2110.
8
Risk Factors for Gastroesophageal Reflux Disease in Saudi Arabia.沙特阿拉伯胃食管反流病的危险因素
Gastroenterology Res. 2017 Oct;10(5):294-300. doi: 10.14740/gr906w. Epub 2017 Oct 26.